Delivery Order SPE2DR25D3103-SPE2DR26F9J57
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.91 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors. The award, issued on November 7, 2025, with a completion date of November 10, 2025, represents a firm fixed-price contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,115.76 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,183.77 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen injectors, with a completion date of November 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued on November 7, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injectors on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price contract, issued without set-aside provisions, represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors valued at $7,807.00, with completion expected by November 26, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order fulfilling pharmaceutical supply requirements for federal military and healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,760.19 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen injectors on September 25, 2025, with completion targeted for September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,932.65 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This firm fixed-price delivery order was competitively awarded without set-aside designation and carries an ultimate completion date of August 8, 2025, one day after the award date. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a ceiling value of $5,137.79 under firm fixed pricing. This award represents a non-competitive delivery order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors at a ceiling value of $1,266.72. This competitively awarded, firm fixed-price delivery order, with an ultimate completion date of October 16, 2025, represents a continuation of pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9J57Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,756.34 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with completion required by November 26, 2025. This firm fixed-price delivery order, issued on November 25, 2025, represents a non-competitive award under DLA's broader pharmaceutical procurement strategy and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, is well-positioned as a critical federal healthcare vendor serving military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical supply vehicle enabling the company to deliver a wide range of medications, vaccines, and medical supplies to support military healthcare programs. The Mounjaro delivery fulfills federal pharmaceutical procurement needs, with the product supporting diabetes management across Department of Defense and related healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 11/24/25 |